TCL Archive In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building October 22, 1999
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983